For pharmaceutical manufacturers engaged in the synthesis of vital drugs like Telmisartan, the procurement of intermediates is a strategic process that directly influences product quality, production efficiency, and cost-effectiveness. Methyl 4-(butyrylamino)-3-methyl-5-nitrobenzoate, identified by its CAS number 152628-01-8, is a critical component in this manufacturing chain.

This pharmaceutical intermediate, typically presented as a white solid, is vital for optimizing the synthesis of Telmisartan, a widely used antihypertensive medication. Its chemical characteristics, including its formula C13H16N2O5, and its role in improving yield and impurity profiles, make it a material of significant interest for R&D scientists and purchasing managers. When considering to buy this compound, buyers are looking for suppliers that offer high purity (often 98% or higher) and consistent batch quality, essential for meeting stringent pharmaceutical standards.

As a global supplier, sourcing this intermediate from China offers distinct advantages, including competitive pricing and large-scale production capabilities. However, it is crucial for buyers to partner with manufacturers who demonstrate a commitment to quality assurance. This involves verifying their adherence to international quality standards, their ability to provide comprehensive technical documentation, and their reliability in meeting delivery schedules. The right supplier should offer flexible ordering options, from small R&D quantities to bulk commercial orders.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to serving the pharmaceutical industry as a premier supplier of Methyl 4-(butyrylamino)-3-methyl-5-nitrobenzoate. We pride ourselves on delivering high-purity intermediates manufactured under rigorous quality control. We encourage interested clients to reach out to us for inquiries and to request a quotation. Our objective is to be your trusted source for this essential Telmisartan intermediate, ensuring a stable and high-quality supply chain for your critical manufacturing needs.

The strategic procurement of high-quality intermediates is a cornerstone of successful pharmaceutical production, directly impacting the availability and efficacy of essential medicines worldwide.